GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Feng Chi Biotech Corp (ROCO:6744) » Definitions » Ending Cash Position

Feng Chi Biotech (ROCO:6744) Ending Cash Position : NT$30.6 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Feng Chi Biotech Ending Cash Position?

Feng Chi Biotech's Ending Cash Position for the quarter that ended in Dec. 2023 was NT$30.6 Mil.

Feng Chi Biotech's quarterly Ending Cash Position declined from Dec. 2022 (NT$65.9 Mil) to Jun. 2023 (NT$58.3 Mil) and declined from Jun. 2023 (NT$58.3 Mil) to Dec. 2023 (NT$30.6 Mil).

Feng Chi Biotech's annual Ending Cash Position increased from Dec. 2021 (NT$48.8 Mil) to Dec. 2022 (NT$65.9 Mil) but then declined from Dec. 2022 (NT$65.9 Mil) to Dec. 2023 (NT$30.6 Mil).


Feng Chi Biotech Ending Cash Position Historical Data

The historical data trend for Feng Chi Biotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feng Chi Biotech Ending Cash Position Chart

Feng Chi Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial 40.24 47.28 48.81 65.90 30.61

Feng Chi Biotech Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.81 58.81 65.90 58.30 30.61

Feng Chi Biotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Feng Chi Biotech's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=65.904+-35.293
=30.6

Feng Chi Biotech's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=58.297+-27.686
=30.6


Feng Chi Biotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Feng Chi Biotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Feng Chi Biotech (ROCO:6744) Business Description

Traded in Other Exchanges
N/A
Address
No. 5, Shaoxing North Street, 5th Floor-1, Zhongzheng District, Taipei City, TWN, 100
Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.

Feng Chi Biotech (ROCO:6744) Headlines

No Headlines